Titan Biotech Financial Statements
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
Y/e 31 Mar | Mar-2020 | Mar-2017 | Mar-2016 | Mar-2015 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 50.60 | 15.20 | 13.50 | -- |
Op profit growth | 151 | 38.90 | (0.50) | -- |
EBIT growth | 151 | 32.60 | 5.70 | -- |
Net profit growth | 224 | 23.30 | 8.35 | -- |
Profitability ratios (%) | ||||
OPM | 17 | 10.20 | 8.44 | 9.63 |
EBIT margin | 15.30 | 9.15 | 7.95 | 8.54 |
Net profit margin | 8.89 | 4.14 | 3.86 | 4.05 |
RoCE | 21.20 | 11.80 | 11.50 | -- |
RoNW | 5.68 | 2.45 | 2.10 | -- |
RoA | 3.09 | 1.33 | 1.40 | -- |
Per share ratios () | ||||
EPS | 9.48 | 2.82 | 2.28 | 2.11 |
Dividend per share | 1 | 0.75 | 0.75 | 0.75 |
Cash EPS | 6.37 | 1.76 | 1.29 | 1.03 |
Book value per share | 47.40 | 29.70 | 27.80 | 26.50 |
Valuation ratios | ||||
P/E | 4.50 | 16.40 | 15.40 | 13.90 |
P/CEPS | 6.69 | 26.20 | 27.20 | 28.60 |
P/B | 0.90 | 1.56 | 1.26 | 1.11 |
EV/EBIDTA | 4.11 | 9.57 | 7.92 | 7.01 |
Payout (%) | ||||
Dividend payout | -- | 26.60 | 39.60 | 42.90 |
Tax payout | (26) | (35) | (33) | (33) |
Liquidity ratios | ||||
Debtor days | 41.80 | 42.40 | 49.20 | -- |
Inventory days | 97.60 | 88.20 | 88 | -- |
Creditor days | (16) | (12) | (14) | -- |
Leverage ratios | ||||
Interest coverage | (5.20) | (3.30) | (3.70) | (3.50) |
Net debt / equity | 0.56 | 0.79 | 0.36 | 0.36 |
Net debt / op. profit | 1.63 | 3.39 | 2.03 | 1.89 |
Cost breakup () | ||||
Material costs | (50) | (62) | (74) | (75) |
Employee costs | (16) | (5.50) | (7.50) | (6.80) |
Other costs | (18) | (22) | (9.90) | (9) |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2017 | Mar-2016 | Mar-2015 |
---|---|---|---|---|
Revenue | 79.40 | 52.70 | 45.80 | 40.30 |
yoy growth (%) | 50.60 | 15.20 | 13.50 | 79 |
Raw materials | (39) | (33) | (34) | (30) |
As % of sales | 49.50 | 62.20 | 74.20 | 74.60 |
Employee costs | (12) | (2.90) | (3.50) | (2.70) |
As % of sales | 15.70 | 5.49 | 7.54 | 6.77 |
Other costs | (14) | (12) | (4.50) | (3.60) |
As % of sales | 17.80 | 22.10 | 9.85 | 8.96 |
Operating profit | 13.50 | 5.36 | 3.86 | 3.88 |
OPM | 17 | 10.20 | 8.44 | 9.63 |
Depreciation | (1.80) | (0.80) | (0.80) | (0.80) |
Interest expense | (2.30) | (1.50) | (1) | (1) |
Other income | 0.45 | 0.28 | 0.55 | 0.40 |
Profit before tax | 9.79 | 3.35 | 2.65 | 2.45 |
Taxes | (2.60) | (1.20) | (0.90) | (0.80) |
Tax rate | (26) | (35) | (33) | (33) |
Minorities and other | (0.80) | -- | -- | -- |
Adj. profit | 6.45 | 2.18 | 1.77 | 1.63 |
Exceptional items | 0.61 | -- | -- | -- |
Net profit | 7.07 | 2.18 | 1.77 | 1.63 |
yoy growth (%) | 224 | 23.30 | 8.35 | 31.40 |
NPM | 8.89 | 4.14 | 3.86 | 4.05 |
- Switch to
-
Tabular DataGraph
Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2017 | Mar-2016 | Mar-2015 |
---|---|---|---|---|
Profit before tax | 9.79 | 3.35 | 2.65 | 2.45 |
Depreciation | (1.80) | (0.80) | (0.80) | (0.80) |
Tax paid | (2.60) | (1.20) | (0.90) | (0.80) |
Working capital | 19.80 | 6.32 | (6.30) | -- |
Other operating items | -- | -- | -- | -- |
Operating cashflow | 25.20 | 7.69 | (5.30) | -- |
Capital expenditure | 24.50 | 2.40 | (2.40) | -- |
Free cash flow | 49.70 | 10.10 | (7.70) | -- |
Equity raised | 37.10 | 27.50 | 28 | -- |
Investments | (0.10) | -- | -- | -- |
Debt financing/disposal | 19.40 | 19 | 26.60 | -- |
Dividends paid | -- | 0.58 | 0.70 | 0.70 |
Other items | -- | -- | -- | -- |
Net in cash | 106 | 57.10 | 47.60 | -- |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Equity capital | 8.26 | 8.26 | 7.74 | 7.74 |
Preference capital | -- | -- | -- | -- |
Reserves | 30.90 | 23.90 | 16.60 | 15.30 |
Net worth | 39.20 | 32.20 | 24.40 | 23 |
Minority interest | ||||
Debt | 23.90 | 23.70 | 25.80 | 22.50 |
Deferred tax liabilities (net) | 1.72 | 1.43 | 1.02 | 0.62 |
Total liabilities | 67.10 | 58.80 | 52.40 | 47.20 |
Fixed assets | 31.20 | 29 | 27 | 22.20 |
Intangible assets | ||||
Investments | -- | -- | -- | -- |
Deferred tax asset (net) | 0.48 | 0.38 | 0.26 | -- |
Net working capital | 33.60 | 27.40 | 23.80 | 20.80 |
Inventories | 28 | 21.10 | 17.60 | 14.50 |
Inventory Days | 129 | -- | -- | 100 |
Sundry debtors | 11.90 | 9.24 | 7.77 | 6.34 |
Debtor days | 54.50 | -- | -- | 43.90 |
Other current assets | 3.12 | 3.30 | 3.22 | 4.88 |
Sundry creditors | (4.40) | (2.60) | (1.70) | (1.40) |
Creditor days | 20.30 | -- | -- | 9.69 |
Other current liabilities | (5) | (3.70) | (3) | (3.60) |
Cash | 1.86 | 2.04 | 1.24 | 4.30 |
Total assets | 67.10 | 58.80 | 52.30 | 47.20 |
- Switch to
-
ConsolidatedStandalone
Particulars ( Rupees In Crores.) | Sep-2020 | Mar-2020 | Sep-2019 | Mar-2019 | Sep-2018 |
---|---|---|---|---|---|
Gross Sales | 72.10 | 38.80 | 40.60 | 32.20 | 32.70 |
Excise Duty | -- | -- | -- | -- | -- |
Net Sales | 72.10 | 38.80 | 40.60 | 32.20 | 32.70 |
Other Operating Income | -- | -- | -- | -- | -- |
Other Income | 0.49 | 0.55 | 0.52 | 0.38 | 0.31 |
Total Income | 72.60 | 39.40 | 41.10 | 32.60 | 33 |
Total Expenditure ** | 43 | 32.50 | 33.50 | 28.10 | 28 |
PBIDT | 29.60 | 6.88 | 7.66 | 4.48 | 5.06 |
Interest | 0.84 | 1.18 | 1.16 | 1.19 | 1.10 |
PBDT | 28.70 | 5.71 | 6.50 | 3.30 | 3.96 |
Depreciation | 0.92 | 0.91 | 0.89 | 0.82 | 0.89 |
Minority Interest Before NP | -- | -- | -- | -- | -- |
Tax | 6.89 | 0.98 | 1.39 | 0.70 | 0.68 |
Deferred Tax | 0.12 | 0.05 | 0.14 | 0.09 | 0.16 |
Reported Profit After Tax | 20.80 | 3.77 | 4.07 | 1.68 | 2.23 |
Minority Interest After NP | 0.85 | 0.08 | 0.69 | 0.11 | 0.28 |
Net Profit after Minority Interest | 20 | 3.69 | 3.38 | 1.57 | 1.95 |
Extra-ordinary Items | 0.07 | 0.26 | 0.26 | -- | -- |
Adjusted Profit After Extra-ordinary item | 19.90 | 3.43 | 3.12 | 1.57 | 1.95 |
EPS (Unit Curr.) | 24.10 | 4.46 | 4.09 | 1.90 | 2.89 |
Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
Dividend (%) | -- | -- | -- | -- | -- |
Equity | 8.26 | 8.26 | 8.26 | 8.26 | 7.74 |
Public Shareholding (Number) | -- | -- | -- | -- | -- |
Public Shareholding (%) | -- | -- | -- | -- | -- |
Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
PBIDTM(%) | 41 | 17.70 | 18.90 | 13.90 | 15.50 |
PBDTM(%) | -- | -- | -- | -- | -- |
PATM(%) | 28.90 | 9.71 | 10 | 5.22 | 6.81 |